Steroid Injections for Plantar Fasciitis
(PF-RCT Trial)
Trial Summary
What is the purpose of this trial?
The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a neurological condition that requires analgesic, anti-seizure, or neuroleptic medications, you may be excluded from participating.
What data supports the idea that Steroid Injections for Plantar Fasciitis is an effective treatment?
The available research shows that steroid injections can be effective for treating plantar fasciitis, but the evidence is not very strong. One study compared steroid injections to platelet-rich plasma (PRP) and found that both treatments helped with plantar fasciitis, but it didn't clearly show that steroids were better. Another study compared steroid injections to botulinum toxin A and a local anesthetic, and it looked at how these treatments affected heel pain and foot movement. While steroid injections are commonly used and can help reduce pain, the research suggests that they are not always more effective than other treatments like PRP or botulinum toxin A.12345
What safety data is available for steroid injections in treating plantar fasciitis?
The safety data for steroid injections in treating plantar fasciitis includes a systematic review and meta-analysis that highlights limited high-quality evidence supporting the treatment. There is a rare case of iatrogenic calcaneal osteomyelitis following a plantar heel injection, suggesting that such injections should be performed in controlled environments to minimize infection risks. Additionally, a randomized controlled trial compared steroid injections with placebo and evaluated the use of ultrasound guidance, indicating ongoing research into optimizing safety and effectiveness.12456
Is the treatment of local steroid injection into the plantar heel a promising treatment for plantar fasciitis?
Research Team
Donald S Malay, DPM
Principal Investigator
Penn Presbyterian Medical Center
Eligibility Criteria
This trial is for adults over 18 with plantar fasciitis, which causes heel pain. It's open to all ethnicities and smokers or non-smokers. People with diabetes without severe nerve damage can join too. But it's not for pregnant women, those with heel fractures or tumors, prior foot surgery within 5 years, chronic widespread pain conditions, allergies to the injections used in the study, bone infections in the heel, substance abuse issues, or certain neurological and vascular diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either ultrasound-guided or anatomic topography-guided corticosteroid injections for plantar fasciitis
Follow-up
Participants are monitored for changes in VAS pain score and foot-related quality of life
Treatment Details
Interventions
- Anatomical Guided injection
- Local Steroid Injection into the plantar heel
- Ultrasound Guided Injection
Local Steroid Injection into the plantar heel is already approved in United States, European Union, Canada for the following indications:
- Plantar fasciitis
- Heel pain
- Plantar fasciitis
- Heel pain
- Plantar fasciitis
- Heel pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor